These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3895086)

  • 21. Parental donors in live-donor kidney transplantation associated with increased rejection rates and reduced glomerular filtration rates.
    Lim WH; Chang SH; Coates PT; McDonald SP
    Transplantation; 2007 Oct; 84(8):972-80. PubMed ID: 17989602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted blood levels of cyclosporin for cardiac transplantation.
    Griffith BP; Hardesty RL; Trento A; Lee A; Bahnson HT
    J Thorac Cardiovasc Surg; 1984 Dec; 88(6):952-7. PubMed ID: 6389991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sixteen months experience with cyclosporin-A in human kidney transplantation.
    Sweny P; Farrington K; Younis F; Varghese Z; Baillod RA; Fernando ON; Moorhead JF
    Transplant Proc; 1981 Mar; 13(1 Pt 1):365-7. PubMed ID: 7022854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with cyclosporine and prednisone as immunosuppressants in 36 renal transplants.
    Kovithavongs T; Boake R; Lakey WH; Ulan RA; Dossetor JB
    Transplant Proc; 1984 Aug; 16(4):1083-5. PubMed ID: 6380055
    [No Abstract]   [Full Text] [Related]  

  • 25. Some experimental and clinical studies of Cyclosporin A in renal transplantation.
    Morris PJ
    Transplant Proc; 1982 Sep; 14(3):525-8. PubMed ID: 6758238
    [No Abstract]   [Full Text] [Related]  

  • 26. Convulsions associated with cyclosporin A in renal transplant recipients.
    Beaman M; Parvin S; Veitch PS; Walls J
    Br Med J (Clin Res Ed); 1985 Jan; 290(6462):139-40. PubMed ID: 3917716
    [No Abstract]   [Full Text] [Related]  

  • 27. Cyclosporin for ever?
    Lancet; 1986 Feb; 1(8478):419-20. PubMed ID: 2868342
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Care of kidney transplant patients using different immunosuppressive drugs].
    Yu PP
    Zhonghua Hu Li Za Zhi; 1987 Apr; 22(4):165-6. PubMed ID: 3308152
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical relevance of N-acetylglucosaminidase determination in urine of kidney transplant recipients with and without cyclosporin A].
    Loertscher R; Scholer A; Brunner F; Harder F; Thiel G
    Schweiz Med Wochenschr; 1982 Nov; 112(46):1658-64. PubMed ID: 6760389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of eleven drug regimens using cyclosporin-A to suppress renal allograft rejection in the dog.
    Homan WP; French ME; Millard PR; Morris PJ
    Transplant Proc; 1981 Mar; 13(1 Pt 1):397-401. PubMed ID: 7022860
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of the clinical, histopathologic, cytologic, and biochemical features of renal transplant rejection, cyclosporine A nephrotoxicity, and stable renal function.
    Taube D; Neild G; Hobby P; Holt D; Welsh K; Cameron JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):179-84. PubMed ID: 3895658
    [No Abstract]   [Full Text] [Related]  

  • 33. [Gingival hyperplasia from cyclosporin A medication].
    Rateitschak-Plüss EM; Hefti A; Rateitschak KH
    SSO Schweiz Monatsschr Zahnheilkd; 1983 Jan; 93(1):57-65. PubMed ID: 6338588
    [No Abstract]   [Full Text] [Related]  

  • 34. [Clinical renal transplantation: exfoliative urinary cytology in the evaluation of nephrotoxicity induced by cyclosporin therapy].
    Stella F; Alfani D; Renna Molajoni E; Rossi M; Rossi Lemeni A; Stella C; Di Tondo U; Troccoli R; Cortesini R
    Quad Sclavo Diagn; 1984 Sep; 20(3):295-303. PubMed ID: 6397762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renal graft survival in patients with systemic lupus erythematosus].
    Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
    Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential diagnosis of Cyclosporin A nephrotoxicity versus rejection by fine needle aspiration biopsy.
    Häyry P; von Willebrand E; Ahonen J
    Proc Eur Dial Transplant Assoc; 1983; 20():356-61. PubMed ID: 6361749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Macroangiopathy of a kidney graft caused by cyclosporin A].
    Jurine N; Guérin C; Kalil C; Broyet C; Veyret C; Berthoux F
    Ann Radiol (Paris); 1989; 32(2):147-9. PubMed ID: 2667434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors affecting graft and patient survival in cadaveric and living kidney transplantation.
    Kim SJ; Lee HH; Lee DS; Lee KW; Joh JW; Woo DH; Kwon GY; Oh HY; Kim YG; Huh WS; Kim DJ; Kim GS; Lee SK; Lee BB
    Transplant Proc; 2004 Sep; 36(7):2038-9. PubMed ID: 15518737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood cyclosporin concentrations and renal allograft dysfunction.
    Lui SF; Varghese Z; Sweny P; Fernando ON; Moorhead JF
    Br Med J (Clin Res Ed); 1986 Nov; 293(6559):1435. PubMed ID: 3099900
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of advanced ovarian epithelial cancer in the renal transplant patient.
    Teneriello M; Farley J; Parker M; O'Connor D; Shaver T; Park R; Barnhill D
    Gynecol Oncol; 1993 Sep; 50(3):374-8. PubMed ID: 8406205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.